ABMC Supplies Save Mart Supermarkets with Its Oral Fluid Devices

KINDERHOOK, N.Y., Jul 30, 2008 (BUSINESS WIRE) -- American Bio Medica Corporation (NASDAQ:ABMC) announced today that they have shipped their first order of its OralStat(R) oral fluid drug tests to Save Mart Supermarkets of Modesto, California, a privately held food store chain. Save Mart has already implemented ABMC's OralStat into their employee drug testing program.

The OralStat is a patented, innovative point of collection testing system for the detection of drugs of abuse in oral fluids. The technology of OralStat provides test results within minutes with enhanced sensitivity and detection comparable to laboratory based oral fluids tests. OralStat can simultaneously test for six drugs in each device.

"We are confident that the OralStat will enhance Save Mart's existing drug testing program and allow them to continue to see the practical and economic advantages of point of collection drug testing," stated ABMC Chief Executive Officer Stan Cipkowski. "Our OralStat continues to be unrivaled in the market for its superior sensitivity and accuracy; allowing employers like Save Mart to optimize their drug testing program and identify drug usage."

"Our top priority is the safety of our customers and our employees," said Jim Pucci, Save Mart Supermarkets VP of Risk Management. "A drug-free workplace is a safe environment and a fast, reliable, on-site test like OralStat brings us closer to that goal."

For more information on American Bio Medica Corporation or its products, please visit www.abmc.com.

For more information on Save Mart Supermarkets, please visit www.savemart.com.

About American Bio Medica Corporation

American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay diagnostic test kits, including some of the world's most effective point of collection tests for drugs of abuse. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC's Rapid Drug Screen(R), Rapid One(R), Rapid TEC(R), RDS(R) InCup(R), Rapid TOX(R) and Rapid TOX Cup(R) products test for the presence or absence of drugs of abuse in urine, while OralStat(R) and Rapid STAT(TM) tests for the presence or absence of drugs of abuse in oral fluids. ABMC's Rapid Reader(R) is a compact, portable device that, when connected to any computer, interprets the results of an ABMC drug screen, and sends the results to a data management system, enabling the test administrator to easily manage their drug testing program.

About Save Mart Supermarkets

Save Mart Supermarkets operates nearly 250 stores throughout Northern California and Northern Nevada under the Save Mart, S-Mart Foods, Lucky, and FoodMaxx banners. The privately-held company was founded January 17, 1952 and has always been headquartered in Modesto, California. More information about the company and its banners is available at www.savemart.com, www.luckysupermarkets.com and www.foodmaxx.com. Its consumer relations group can be called toll-free at 800-692-5710.

This release may contain forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results to differ, and such differences could be material. Such risks and uncertainties include, but are not limited to, the following: continued acceptance of the Company's products, increased levels of competition in our industry, the acceptance of new products, inherent risks associated with product development, regulatory approvals and intellectual property rights, the Company's dependence on key personnel, third party sales and suppliers. There can be no assurance that the Company will be successful in addressing such risks and uncertainties and the Company assumes no duty to update any forward-looking statements based upon actual results. Investors are strongly encouraged to review the section entitled "Risk Factors" in the Company's annual report on Form 10-KSB for the fiscal year ended December 31, 2007, and quarterly reports on Form 10-QSB on file with the Securities and Exchange Commission for a discussion of risks and uncertainties that could affect operating results and the market price of the Company's common shares.

SOURCE: American Bio Medica Corporation

American Bio Medica Corporation
Stan Cipkowski, 800-227-1243, Ext 106
Chief Executive Officer